UTEK Corporation And CytoDyn Complete Technology Transfer

TAMPA, Fla. & SANTA FE, N.M. & BOSTON--(BUSINESS WIRE)--UTEK Corporation (AMEX:UTK) (LSE-AIM:UTK), a specialty finance company focused on technology transfer, and CytoDyn, Inc. (Pink Sheets:CYDY), a development stage biotechnology company, today announced CytoDyn has acquired Advanced Genetic Technologies, Inc., a wholly owned subsidiary of UTEK, in a stock transaction.

Back to news